The global amyloidosis treatment market is on a trajectory of significant expansion, driven by heightened disease awareness, ...

From mobile jobs to nature photography, BLUETTI aims at all profiles. The fast charging of Canon, DJI, or Apple batteries ensures the success of photo shoots away from the grid. The station thus ...

BioNTech SE (NASDAQ:BNTX) is one of the Stocks That Will Go To The Moon in 2026. On December 18, BioNTech SE (NASDAQ:BNTX) ...

Quick Machine Recovery was introduced in November 2024 as part of Microsoft's Windows Resiliency Initiative at Ignite 2024, in response to a massive July 2024 outage caused by a buggy CrowdStrike ...

Data entry errors in DWI testing equipment may impact at least 277 cases and have prompted the Minnesota Bureau of Criminal Apprehension to order a statewide inspection of the instruments. According ...

The stars have aligned for Bristol Myers Squibb and Orbital Therapeutics. Pushing deeper into in vivo cell therapies, BMS has agreed to pay $1.5 billion to buy the biotech for a pipeline led by a ...

Pickering Interfaces has added two PXI and two PXIe battery simulators to its line of PXI test modules. The 41-754 (PXI) and 43-754 (PXIe) battery simulators are both available in 2-channel or ...

Pickering Interfaces, the leading supplier of modular signal switching and simulation solutions for use in electronic test and verification, has announced a major new addition to its range of PXI ...

Pickering Interfaces, the leading supplier of modular signal switching and simulation solutions for use in electronic test and verification, has announced a major new addition to its range of PXI ...

PXI/PXIe solution offers scalable, modular design for faster development cycles and lower total cost of ownership, plus improved safety Pickering Interfaces, the leading supplier of modular signal ...

PXI/PXIe solution offers scalable, modular design for faster development cycles and lower total cost of ownership, plus improved safety CLACTON-ON-SEA, England–(BUSINESS WIRE)–Pickering Interfaces, ...

NEW YORK – Bristol Myers Squibb is betting that CAR T-cell therapy, having been a game changer in oncology, can "reset" the immune system for patients with relapsing or progressive multiple sclerosis.